Abstract:The present study aims to synthesize new thiadiazole/oxadiazole fused thiadiazole derivatives, incorporating pyridine moiety as effective inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) to treat Alzheimer disease. Initially, pyridine based thiosemicarbazone was synthesized by treating pyridine 2,6-dicarboxaldehyde with thiosemicarbazide. Thiosemicarbazone was cyclized into bis-thiadiazole, which further react with different isothiocyanates to give pyridine-based bis-(thiadiazole-fused-thiadiazole) derivatives (4a-h) . Next pyridine based semicarbazone was synthesized by treating pyridine 2,6-dicarboxaldehyde with semicarbazide. Then semicarbazone was cyclized into bis-oxadiazole which further react with different isothiocyanates to give pyridine-based bis-(oxadiazole-fused-thiadiazole) derivatives (7a-h) .The synthetic analogs were structurally elucidated through 1 H NMR, 13 C NMR and HRMS (EI) analysis and assessed for acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitory potential. All synthetic analogues showed varying degrees of inhibitory effects on AChE and BuChE, with IC 50 value ranging from 12.89 ± 1.10 μM - 61.76 ± 2.40 μM for AChE and 14.79 ± 1.20 μM - 56.87 ± 2.50 μM for BuChE in comparison of standard inhibitor Galantamine (IC 50 = 37.40 ± 1.20 μM for AChE and IC 50 = 41.20 ± 1.90 μM for BuChE). Among the series, analogues 4c IC 50 = 13.32 ± 1.30 μM (against AChE), and 15.17 ± 1.40 μM (against BuChE), and 7c IC 50 = 12.89 ± 1.10 μM (against AChE) and 14.79 ± 1.20 μM (against BuChE) exhibited notable inhibitory activity against AChE and BuChE enzymes, Moreover, molecular docking studies were conducted on potential analogues to investigate their binding interactions with the targeted enzyme's active sites.

Synthesis, Biological Evaluation, and In Silico Studies of New Acetylcholinesterase Inhibitors Based on Quinoxaline Scaffold

Simple Analogues of Natural Product Chelerythrine: Discovery of a Novel Anticholinesterase 2-Phenylisoquinolin-2-ium Scaffold with Excellent Potency Against Acetylcholinesterase

Synthesis, in vitro biological evaluation and in silico molecular docking study of hydroxy‐quinoline based sulfonohydrazide derivatives as potential acetylcholinesterase and butyrylcholinesterase inhibitors

( S )- N -Benzyl-1-phenyl-3,4-dihydroisoqunoline-2(1 H )-carboxamide Derivatives, Multi-Target Inhibitors of Monoamine Oxidase and Cholinesterase: Design, Synthesis, and Biological Activity.

Design, Synthesis, Biological Evaluation, and Molecular Modeling Studies of Quinoline-Ferulic Acid Hybrids As Cholinesterase Inhibitors.

Design, Synthesis and Biological Evaluation of Pyrano[2,3-b]-naphthoquinone Derivatives as Acetylcholinesterase Inhibitors

2-(2-Indolyl-)-4(3h)-quinazolines Derivates As New Inhibitors of AChE: Design, Synthesis, Biological Evaluation and Molecular Modelling

Synthesis and biological evaluation of novel flavonoid derivatives as dual binding acetylcholinesterase inhibitors.

Synthesis, computational docking and molecular dynamics studies of a new class of spiroquinoxalinopyrrolidine embedded chromanone hybrids as potent anti-cholinesterase agents

Structure-based inhibition of acetylcholinesterase and butyrylcholinesterase with 2-Aryl-6-carboxamide benzoxazole derivatives: synthesis, enzymatic assay, and in silico studies

[Synthesis and AchE Inhibitory Activity of 2-Phenoxy-indan-1-one Derivatives].

Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease

Design, synthesis, biological evaluation, and docking study of 4-isochromanone hybrids bearing N-benzyl pyridinium moiety as dual binding site acetylcholinesterase inhibitors (part II).

Synthesis, biological evaluation and molecular modeling of substituted 2-aminobenzimidazoles as novel inhibitors of acetylcholinesterase and butyrylcholinesterase.

Design, Synthesis and Pharmacological Evaluation of Chalcone Derivatives As Acetylcholinesterase Inhibitors

Development of promising acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, in vitro and in silico approaches of pyridine derived fused bis-oxadiazole and bis-thiadiazole derivatives

New imidazo[1,2-a]pyridin-2-yl derivatives as AChE, BChE and 15-LOX inhibitors; design, synthesis, and biological evaluation

Design, Synthesis and Molecular Modeling of Isothiochromanone Derivatives As Acetylcholinesterase Inhibitors

A Series of Novel 1- H-isoindole-1,3(2 H)-dione Derivatives as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: In Silico, Synthesis and In Vitro Studies

Novel bis-thiazole-thiazolidinone hybrid derivatives: Synthesis, structural properties and anticholinesterase bioactive potential as drug competitor based on docking studies

New 2-Aryl-9-methyl-β-carbolinium salts as Potential Acetylcholinesterase Inhibitor agents: Synthesis, Bioactivity and Structure–Activity Relationship